As the fallout from the reversal of Roe v. Wade continues, contraception is top of mind for many people. The U.S. House of Representatives this week voted to protect the right to contraception at the federal level, but the bill now heads to the Senate where it could face roadblocks. But one pharmaceutical company has a potential solution. HRA Pharma has filed an FDA application for the first ever daily, over-the-counter birth control pill. What would this mean for millions of people who face barriers to access, and how will it make a difference in the fight for the protection of contraceptives? Stephanie Sober, U.S. Medical Liaison for HRA Pharma, joins Closing Bell to discuss.